Translating Scientific Breakthroughs into Promise for Patients

From discovery through commercialization, all of us at Ardelyx® are driven to advance patient care with targeted, first-in-class, novel mechanism therapies that address significant unmet medical needs. We developed a unique and innovative platform that enabled the discovery of new biological mechanisms and pathways to create targeted, first-in-class, oral, small molecule therapies.

With Integrity and Dedication, We Make a Difference for Patients

Join Us

We are… Passionate. Fearless. Dedicated. Inclusive!

Patients & Families

Translating scientific breakthroughs into promise for patients.

For Investors

Creating value from

Recent News

July 18, 2024

Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024

July 17, 2024

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and...

July 2, 2024

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA